[Sarcopenia, frailty and osteoporosis.]

Area of Science:

• Gerontology
• Musculoskeletal Health
• Metabolic Bone Disease

Background:

• Aging leads to decreased skeletal muscle mass and strength (sarcopenia) and bone density (osteoporosis).
• Sarcopenia and osteoporosis are closely linked anatomically and increase risks of falls, fractures, and disability.
• Vitamin D is implicated in the pathophysiology of both conditions, necessitating attention to its role.

Purpose of the Study:

• To explain sarcopenia in the context of aging and frailty.
• To describe diagnostic methods for sarcopenia.
• To outline treatment strategies for sarcopenia based on pathophysiology.

Main Methods:

• Review of existing literature on sarcopenia, osteoporosis, and aging.
• Analysis of the pathophysiological mechanisms linking muscle and bone aging.
• Discussion of diagnostic criteria and therapeutic interventions for sarcopenia.

Main Results:

• Skeletal muscle and bone exhibit similar age-dependent declines.
• Both sarcopenia and osteoporosis elevate risks for falls, fractures, and disability.
• Gender differences exist, with osteoporosis more prevalent in postmenopausal women and muscle decline more common in men.

Conclusions:

• Sarcopenia and osteoporosis share common aging pathways and risks.
• Vitamin D is a potential factor in the etiology and management of both conditions.
• Understanding sarcopenia's pathophysiology is crucial for diagnosis and treatment, especially in aging populations.